Cases
-
Latest cases
Compass Lexecon Client the SEC Prevails in Civil Securities Fraud Action
Court Relies on Opinions of Compass Lexecon Senior Consultant Professor Kenneth M. Lehn
-
Latest cases
DOJ Drops All Criminal Charges Against Compass Lexecon Client Gautam Adani in Securities Fraud Case
Compass Lexecon Affiliate Professor Allen Ferrell Submits Expert Report
-
Latest cases
Jeremy Verlinda Serves as Expert Economist for FTC in Zillow-Redfin Antitrust Challenge
-
Latest cases
Tahweel Holding completes acquisition of plastics conversion firm Al Rowad Industrial Transformation Company
-
Latest cases
Abra Group receives green light to take over low-cost carrier SKY Airline
-
Latest cases
Celanese, Clariant and co-defendants secure victory over Shell and Repsol in ethylene damages litigation in the Netherlands
-
Latest cases
Compass Lexecon Client Corning Secures Major ITC Victory in Display Glass Trade Secret Litigation
Court Relies Heavily on Testimony of Compass Lexecon President and Chairman Professor Daniel R. Fischel
-
Latest cases
Competition and Consumer Commission of Singapore wins first-ever appeal to the High Court of Singapore
Showing 1–16 of 70 results
-
The US Securities and Exchange Commission (“SEC”) alleged that Brian K. Hutchison made material misrepresentations to investors while he was the Chief Executive Officer of RTI Surgical Holdings,…
-
02 Apr 2026
Compass Lexecon advised Thermo Fisher Scientific (‘Thermo Fisher’) during the European Commission (‘EC’)’s review of Thermo Fisher’s acquisition of Clario Holdings. -
04 Feb 2026
Compass Lexecon assisted CUF – Sociedade Gestora de Participações, S.A. (‘CUF’) during Phase II merger proceedings by the Portuguese competition authority, reviewing CUF’s acquisition of majority… -
18 Sept 2025
Compass Lexecon advised Thermo Fisher Scientific (‘Thermo Fisher’) and Solventum in the context of Thermo Fisher’s acquisition of Solventum’s Purification and Filtration business in the… -
11 Aug 2025
On August 7, 2025, UnitedHealth Group (UHG) settled its litigation with the U.S. Department of Justice and several State Co-Plaintiffs, clearing the path to close its $3.3 billion acquisition of… -
21 Jul 2025
Plaintiffs alleged that AbbVie, its chief executive officer, and former chief financial officer fraudulently misled investors by concealing that the company had violated the federal Anti-Kickback… -
28 Apr 2025
A new study of the pharmacy benefit manager (PBM) industry was released by Professor Dennis Carlton, one of the leading industrial organization economists in the country and a former Deputy… -
22 Apr 2025
U.S. District Court Judge Paul S. Diamond for the Eastern District of Pennsylvania granted summary judgment mid-trial in favor of Compass Lexecon’s client DePuy Synthes in a patent infringement… -
On September 20, 2024, Johnson & Johnson subsidiary Red River Talc (RRT) filed a prepackaged bankruptcy to resolve the tens of thousands of pending and future personal injury claims alleging…
-
03 Apr 2025
Co-Diagnostics retained Compass Lexecon and Senior Consultant Professor Allen Ferrell to rebut the Plaintiff’s expert’s opinions on loss causation and damages. -
20 Nov 2024
A jury ruled in favor of Compass Lexecon’s client, the City of Baltimore (the City), in a trial against several pharmaceutical distributors (Defendants). The jury ruled that the Defendants’… -
09 Oct 2024
Dennis W. Carlton, Mary Coleman, Nauman Ilias, Theresa Sullivan, and Nathan Wilson conducted a study, commissioned by Caremark, Express Scripts, and Optum Rx, that focuses on the role of pharmacy… -
13 Aug 2024
On August 1, 2024, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics. The deal closed after a merger review by the U.S. Federal Trade Commission. A Compass Lexecon team led… -
03 Apr 2024
Compass Lexecon’s client Express Scripts defeated a motion for certification of putative classes of direct and indirect purchasers of the specialty drug Acthar. -
08 Jan 2024
On December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen – the largest M&A deal in biopharma since 2019. The deal closed after merger reviews by competition authorities around… -
13 Sept 2023
Compass Lexecon worked closely with the merging parties on this matter, starting with a team advising Horizon on the merger (led by Mark Israel) and proceeding to the submission of expert reports…
Our professionals
Compass Lexecon’s staff includes more than 700 employees, including professional consultants, analysts, and practice support personnel that span 23 offices across the globe.
